Company: APXIF
Filing Date: 2025-07-03
Form Type: F-4/A
Source: 0001213900-25-061545
Chunk: 418

Company: APx Acquisition Corp. I
Filing Date: 2025-07-03
Form: F-4/A
Chunk 418
---
 was due to the hiring of new personnel, resulting in higher compensation expenses and related administrative costs such as benefits, and other overhead. Research and Development Expenses Research and development expenses increased by $95,395, or 42.5%, from $224,298 for the six months ended December 31, 2023, to $319,693 for the six months ended December 31, 2024. This increase was mainly due to an increase in higher personnel costs due to salary adjustments and staffing changes within the R&D team. No R&D expenses during this period were allocated to the development of new products or services. Finance income Finance income decreased by $9,589, or 72.3%, from $13,265 for the six months ended December 31, 2023, to $3,676 for the six months ended December 31, 2024, primarily due to a lower allocation of excess cash to mutual fund investments. Finance costs Finance costs increased by $202,201, or 197.3%, from $102,482 for the six months ended December 31, 2023, to $304,683 for the six months ended December 31, 2024. The increase was primarily due to higher interest expenses arising from loans with shareholders and related parties, which accounted for the largest portion of the increase. In addition, a smaller portion of the increase was due to interest on discounted deferred checks with financial institutions. The Company opted to discount deferred checks received from CIBIC at the bank to accelerate cash flow and avoid waiting for the maturity of the checks, which were originally due in 60 days. This decision allowed the Company to obtain cash earlier by paying a discount to the bank, which led to an increase in financial expenses related to interest charges in respect of these transactions. While this strategy improved liquidity and provided faster access to funds, the associated costs were reflected in the higher finance costs during the period. Other financial results, net Other financial results, net, decreased by $946,650, or 65.4%, from $1,447,763 for the six months ended December 31, 2023, to $501,113 for the six months ended December 31, 2024. The decrease was primarily due to a lower impact from foreign exchange differences. In contrast to the prior year, the Company experienced more stable exchange rates, resulting in a reduced positive effect from the revaluation of foreign currency -denominatedliabilities, including shareholder loans and payments to international suppliers